GROUP 2 PULMONARY HYPERTENSION
Clinical trials for GROUP 2 PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new GROUP 2 PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for GROUP 2 PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New procedure aims to ease breathing in heart failure patients
Disease control ENROLLING_BY_INVITATIONThis study tests a new procedure called pulmonary artery denervation for people with heart failure and a type of high blood pressure in the lungs (Group 2 PH). The procedure uses a special device to calm overactive nerves in the lung arteries, which may improve blood flow and qua…
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: NA • Sponsor: Gradient Denervation Technologies • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
Heart failure drug trial pulled before it began
Disease control TerminatedThis study was designed to test the safety and effects of a drug called JK07 in people with heart failure and a specific type of high blood pressure in the lungs. It planned to enroll about 20 to 30 adults aged 18 to 85. However, the trial was withdrawn before any participants we…
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: PHASE2 • Sponsor: Salubris Biotherapeutics Inc • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
Could a common ED drug help Lung-Heart patients walk farther?
Disease control OngoingThis study tests whether tadalafil, a drug often used for erectile dysfunction, can help people with group 2 pulmonary hypertension (high blood pressure in the lungs linked to heart disease). About 48 adults will take tadalafil or a placebo for 12 weeks. Researchers will measure …
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control
Last updated May 26, 2026 07:26 UTC